Debating Small Differences
The European Court of Justice has been wrestling with a set of sticky questions: to what extent should the existence of a new version of a drug influence what becomes of a previous version? The case that is raising these issues was filed by Rhone-Poulenc Rorer in June 1997, as a protest against a decision by the UK Medicines Control Agency, which granted a parallel import license for an old version of RPR's insomnia treatment zopiclone.
You may also be interested in...
Netherlands' Medicines Evaluation Board says the safety of paracetamol is "not up for debate" after a media investigation reported contamination of the drug with a possible human carcinogen.
There is speculation that it is the end of the road for abicipar pegol but Allergan has declined to say whether this is the case for the product that has been in development for wet AMD.
In the EU, voices calling for a postponement of the IVD Regulation’s 2022 enforcement date are growing louder.